Ozempic Injection (Semaglutide)

Ozempic contains semaglutide, a GLP-1 receptor agonist used with diet and exercise to improve blood glucose control in adults with insufficiently controlled type 2 diabetes. Treatment with Ozempic may also result in weight reduction in eligible patients. It is administered by subcutaneous injection according to the prescribed treatment regimen.

Key Features & Specifications

Active ingredient: Semaglutide
Medicine class: GLP-1 receptor agonist
Administration: Subcutaneous injection
Dosing: Once weekly
Strengths: 0.25 mg, 0.5 mg, 1 mg, 2 mg
Use: Type 2 diabetes management alongside diet and exercise
Manufacturer: Novo Nordisk
Availability: Prescription medicine

Price range: €118,00 through €280,00

Dosage	Clear

Compare

Add to wishlist

SAVE 15%

more 2 products

SAVE 50%

6 for the price of 3

* The information on this page is a summary and is not intended to cover all available information about this medication. It does not cover all possible uses, directions, precautions, drug interactions or adverse effects and is not a substitute for the expertise and judgement of your healthcare professional.